Features | Partner Sites | Information | LinkXpress
Sign In
SCHILLER AG
AMPRONIX
TERARECON, INC.

Ultrafast CT Scanner Designed for Optimized Cardiology

By Medimaging International staff writers
Posted on 25 Feb 2014
Image: GE Healthcare’s Revolution CT system (Photo courtesy of GE Healthcare).
Image: GE Healthcare’s Revolution CT system (Photo courtesy of GE Healthcare).
A new computed tomography (CT) system freezes the heart’s motion in just one heartbeat without losing image quality.

GE Healthcare (Chalfont St. Giles, UK) presented at Arab Health 2014, a Middle East and Africa healthcare conference, held in Dubai (UAE), in January 2014, its ultra-fast CT scanner, US Food and Drug Administration (FDA)510(k)-pending Revolution CT, which captures a motion-free image of the human heart in just one beat. This cutting-edge technology enables clinicians to noninvasively visualize the human heart more clearly than ever before, and diagnose more patients with erratic or high heartbeats.

According to research published in the British Journal of Radiology, more than 60% of patients referred to cardiac CT were found to have heart rates higher than 60 beats per minute, and some are turned away from being scanned. With Revolution CT, clinicians can clearly see specific areas of the heart that were previously compromised either by a patient’s movement, high heart rate, or a child’s inability to hold his or her breath.

Maher Abouzeid, president and CEO of GE Healthcare for the Middle East and Pakistan, said, “It is estimated that the cost of noncommunicable diseases across the GCC region will reach over USD 36 billion, and the financial burden to diagnose and treat them is expected to increase to USD 68 billion by 2022, if timely measures are not taken […]. In a cost-constrained healthcare environment, clinicians need one definitive test that gives them the diagnostic confidence to make the right treatment decision for their patients. GE Healthcare’s Revolution CT makes this possible through the convergence of spatial resolution, temporal resolution, coverage, and low dose all-in-one, providing uncompromised image quality and clinical capabilities.”

The Revolution CT enables comprehensive cardiac exams with anatomic and functional information in just one heartbeat, even with challenging patients and higher heart rates; rapid, whole-brain stroke assessment at low dose and dynamic liver, pancreas, or kidney oncology workup customized with perfusion and vascular flow analysis.

The Revolution CT has features that include the 16-cm Gemstone Clarity detector for whole organ coverage, excellent spatial resolution at 230 micrometers for visualizing small anatomy, and a 0.28 second gantry designed and tested for up to 0.2 second rotation speed. Combined with SnapShot Freeze motion correction technology, the system delivers 24 millisecond effective temporal resolution for high heart rate imaging without restrictions.

The Revolution CT continues GE’s focus on lower CT doses, with innovations such as the new Gemstone Clarity detector, a 70-kVp scan mode for pediatric use, and ASiR [adaptive statistical iterative reconstruction]-V, GE’s next-generation iterative reconstruction technology. For the patient, the system provides a wider, more comfortable 80-cm bore and a quiet scanning experience with the new Whisper Drive system. Ultra-fast scanning with streamlined workflow makes it a suitable scanner for emergency rooms.

The Revolution system is 510(k)-pending from the US Food and Drug Administration (FDA) and not yet available for sale in the United States. It is also not yet CE market-approved, and is not available for sale in all regions.

Related Links:

GE Healthcare



RTI ELECTRONICS AB
RADCAL
SuperSonic Imagine

Channels

MRI

view channel

Use of Breast MRI Offers Optimized Care

Magnetic resonance imaging (MRI) is being used increasingly for breast cancer screening, diagnostic assessment, treatment planning, and monitoring; however, a recent study revealed that over time, the indication for breast MRI has changed. Much of the increase was found among women with breast cancer risk factors, but there... Read more

Ultrasound

view channel
Image: Analogic Sonic Window handheld ultrasound for peripheral IV placement (Photo courtesy of Analogic).

First-of-a-Kind Ultrasound System Designed for Image-Guided Peripheral Intravenous Access and Fits in Pocket

A new, ultra-compact ultrasound device provides direct visualization of structures beneath the skin in real time to effectively guide clinicians placing peripheral intravenous (IV) lines.... Read more

Nuclear medicine

view channel
Image: Micrograph of Hodgkin lymphoma. Lymph node fine-needle aspiration (FNA) specimen. Field stain (Photo courtesy of Wikimedia Commons).

Early PET-Negative Stage I/II Hodgkin Lymphoma Patients Show Increased Risk of Early Relapse when Radiotherapy Is Not Used

Analysis of a new study indicates an increased risk of early relapse when excluding radiotherapy in early positron emission tomography (PET) scan-negative patients with stage I/II Hodgkin’s lymphoma.... Read more

General/Advanced Imaging

view channel

Secondary Light Emission Generated by Plasmonic Nanostructures May Improve Medical Imaging Technology

New clues into light emission at different wavelengths generated by elements known plasmonic nanostructures may help to improve medical imaging technology. A plasmon is a quantum of plasma oscillation. The plasmon is a quasiparticle resulting from the quantization of plasma oscillations just as photons, and phonons are... Read more

Imaging IT

view channel

Enterprise Image-Viewing System Receives FDA Clearance for Mobile Diagnosis on All Modalities

An enterprise image-viewing system is now cleared in the United States for diagnosis on mobile devices, for all imaging modalities (except mammography). Calgary Scientific, Inc. (Calgary, AB, USA) recently reported their latest Class II clearance from the US Food and Drug Administration (FDA). Calgary Scientific worked... Read more

Industry News

view channel

Collaboration Expands Capacity for Proton Therapy Clinical Research and Patient Treatments

Varian Medical Systems (Palo Alto, CA, USA) and the Paul Scherrer Institute (PSI; Villigen PSI, Switzerland) are extending an existing collaboration in the field of proton therapy to offer patients more accurate cancer treatments using intensity-modulated proton therapy (IMPT). Under the agreement, Varian will also... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.